Skip to main content

Table 6 Comparisons of IL between curcumin supplement and placebo

From: Effect of curcumin supplement or placebo in delayed onset muscle soreness: a systematic review and meta-analysis

Author Curcumin Placebo
N Mean SD N Mean SD
(a) IL preexercise
Nicol LM 17 0 0 17 0 0
Tanabe Y 14 0.85 0.14 14 0.7 0.14
McFarlin BK 14 2.84 0.41 14 3.51 0.68
Tanabe Y scan pre 10 2.66 0.41 10 2.33 0.25
Tanabe Y scan post 10 2.58 0.41 10 2.62 0.66
Mallard AR (0–10) 13 12.1 10.1 14 10.1 22
UMD (95% CI)      − 0.03 (− 0.35. 0.32)   
(b) IL at 24 h
Nicol LM 17 0 0 17 0.42 1.875
Tanabe Y 14 0.77 0.21 14 1.13 0.56
McFarlin BK 14 2.36 0.41 14 3.72 0.68
Tanabe Y scan pre 10 2.7 0.5 10 3.11 0.99
Tanabe Y scan post 10 2.99 0.33 10 2.7 0.86
Mallard AR (0–10) 13 13.5 10.7 14 10.7 11.1
UMD (95%CI)      − 0.46 (− 1.12, 0.02)   
(c) IL at 48 h
Nicol LM 17 0.56 1.03 17 0 0
Tanabe Y 14 0.92 0.28 14 0.92 0.42
McFarlin BK 14 2.5 0.34 14 3.58 0.68
Mallard AR (0–10) 13 14.4 12 14 12 11.6
UMD (95%CI)      − 0.49 (− 1.52, 0.54)   
(d) IL at 72 h
Tanabe Y 14 0.92 0.42 14 1.27 0.56
McFarlin BK 14 2.64 0.41 14 3.45 0.68
Tanabe Y scan pre 10 3.15 0.58 10 2.82 0.62
Tanabe Y scan post 10 2.53 0.82 10 2.78 0.49
Mallard AR (0–10) 13 12.2 11.6 14 11.7 10
UMD (95%CI)      − 0.29 (− 0.72, 0.14)   
(e) IL at 96 h
Tanabe Y 14 1.76 2.53 14 1.9 1.97
McFarlin BK 14 2.3 0.41 14 3.51 0.68
UMD (95%CI)      − 1.00 (− 1.83, − 0.16)